Related references
Note: Only part of the references are listed.The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants
Stefanie Andrea Knoepfel et al.
JOURNAL OF VIROLOGY (2008)
Human Immunodeficiency Virus Type 1 Replication and Regulation of APOBEC3G by Peptidyl Prolyl Isomerase Pin1
Koichi Watashi et al.
JOURNAL OF VIROLOGY (2008)
Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins
Sarah Gallois-Montbrun et al.
JOURNAL OF VIROLOGY (2008)
Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1
Marc-Andre Langlois et al.
JOURNAL OF VIROLOGY (2008)
The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction
April J. Schumacher et al.
JOURNAL OF VIROLOGY (2008)
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
Kotaro Shirakawa et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation
Hal P. Bogerd et al.
RNA (2008)
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
Jenny L. Anderson et al.
VIROLOGY (2008)
APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication
Yanxing Han et al.
PLOS PATHOGENS (2008)
7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G
Tao Wang et al.
JOURNAL OF VIROLOGY (2007)
Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1
Eri Miyagij et al.
JOURNAL OF VIROLOGY (2007)
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Yasumasa Iwatani et al.
NUCLEIC ACIDS RESEARCH (2007)
APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription
Xiao-Yu Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA
Fei Guo et al.
JOURNAL OF VIROLOGY (2007)
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity
Beth K. Thielen et al.
PLOS PATHOGENS (2007)
Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F
Yiliang Yang et al.
VIROLOGY (2007)
Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions
Mohammad A. Khan et al.
RETROVIROLOGY (2007)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions
Hongzhan Xu et al.
VIROLOGY (2007)
APOBEC3 inhibits mouse mammary tumour virus replication in vivo
Chioma M. Okeoma et al.
NATURE (2007)
Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H
Vanessa B. Soros et al.
PLOS PATHOGENS (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
APOBEC-mediated viral restriction: not simply editing?
Rebecca K. Holmes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv
Fei Guo et al.
JOURNAL OF VIROLOGY (2006)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Biochemical activities of highly purified, catalytically active human APOBEC3G: Correlation with antiviral effect
Yasumasa Iwatani et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
L Chelico et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G
SM Kaiser et al.
JOURNAL OF VIROLOGY (2006)
APOBEC-mediated interference with hepadnavirus production
C Rösler et al.
HEPATOLOGY (2005)
被撤回的出版物: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
YL Chiu et al.
NATURE (2005)
Complementary function of the two catalytic domains of APOBEC3G
F Navarro et al.
VIROLOGY (2005)
G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
TL Kieffer et al.
JOURNAL OF VIROLOGY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Inhibition of hepatitis B virus replication by APOBEC3G
P Turelli et al.
SCIENCE (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)
Role of Vif in stability of the human immunodeficiency virus type 1 core
Å Ohagen et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
